Fierce editors Carly Helfand and Damian Garde discuss Valeant Pharmaceuticals' latest reclamation projects, the bad-cholesterol horse race between Sanofi and Amgen, and Novartis' apparent horror-movie aspirations. Peace to Wes Craven.
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More